Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2Gastrointestinal 2Breast 2Other hematologic neoplasm 1NET 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 2

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15Sunitinib 14Filgrastim 14Early Intervention, Educational 14atezolizumab 13alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Acupressure × Other solid neoplasm × Clear all
NCT06442891 2026-01-21

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

University of Michigan Rogel Cancer Center

Phase NA Completed
42 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06322615 2025-10-29

Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy

Mayo Clinic

Phase NA Completed
30 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡